BioCardia
BCDA
18 hedge funds and large institutions have $831K invested in BioCardia in 2026 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 6 closing their positions.
150% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 2
2% more capital invested
Capital invested by funds: $812K → $831K (+$18.8K)
0.15% more ownership
Funds ownership: 6.12% → 6.28% (+0.15%)
0% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 6
10% less funds holding
Funds holding: 20 → 18 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PP
Pingora Partners
Wilson,
Wyoming
|
+$40.9K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$35.4K |
| 3 |
VF
Virtu Financial
New York
|
+$25.5K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$18.5K |
| 5 |
Renaissance Technologies
New York
|
+$17.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DS
DRW Securities
Chicago,
Illinois
|
-$72K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$38.6K |
| 3 |
Wealth Enhancement Advisory Services
Plymouth,
Minnesota
|
-$25.4K |
| 4 |
Two Sigma Investments
New York
|
-$14K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$14K |
BCDA Hedge Fund Activity: Q1 2026 in Review
18 of the 8,127 institutional investors tracked by Wall St. Rank reported a position in BioCardia (BCDA) for Q1 2026, worth a combined $831K — up 2.3% from $812K a quarter earlier.
Fund positioning in BCDA was balanced in Q1 2026: 6 funds opened new positions, 6 closed out, 5 added to existing stakes and 2 trimmed.
The largest buyer was Pingora Partners, adding an estimated $40.9K. The largest seller was DRW Securities, exiting entirely with an estimated $72K sold.
- 18 institutional investors held BioCardia (BCDA) as of Q1 2026, down from 20 in Q4 2025.
- Funds reported $831K of BioCardia stock for Q1 2026, up 2.3% quarter-over-quarter.
- 6 funds opened new BioCardia positions in Q1 2026 and 6 closed out, a net change of 0 holders.
- The largest BioCardia buyer in Q1 2026 was Pingora Partners, an estimated $40.9K added.
- The largest BioCardia seller in Q1 2026 was DRW Securities, an estimated $72K sold.
Based on aggregated 13F filings for Q1 2026.